Medical Devices Investors & VC Firms

1393 firms in this list, with a median first check of $500K. 266 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
NE New World Angels RTADAJAY37 people · Follows rounds	88🔒	Boca Raton	US	Seed–Series A	—	+ Add to CRM
DO DOMiNO Ventures MKYKBYAK30 people · Leads rounds	88🔒	Amsterdam	NL	Seed–Series B	$220K – $1.1M	+ Add to CRM
KA Karista ABBHCBED14 people · Leads rounds	88🔒	Paris	FR	Pre-Seed–Late Stage	$324K – $5.4M	+ Add to CRM
NA NaviMed Capital BSBCRSRR29 people	88🔒	Rosslyn	US	Growth	$5M – $30M	+ Add to CRM
SA Safar Partners GSBMRMAC20 people	88🔒	Cambridge	US	Pre-Seed–Late Stage	—	+ Add to CRM
TR Trendlines Group HBTDBSNK21 people	88🔒	Misgav	IL	Pre-Seed–Late Stage	$650K – $15M	+ Add to CRM
UT UTEC KM1 person · Follows rounds	88🔒	Tokyo	JP	Pre-Seed–Growth	$3.1M – $78M	+ Add to CRM
AM aMoon IDMMRSRW25 people	88🔒	Ra'anana	IL	Seed–Late Stage	—	+ Add to CRM
CL ClavystBio FAKSKLAT33 people	88🔒	Singapore	SG	Seed–Series A	—	+ Add to CRM
CI CitareTx Investment Partners JSE"2 people · Leads rounds	88🔒	Houston	US	Seed–Series A	$500K – $2M	+ Add to CRM
NO Noro-Moseley Partners AMATSMVK10 people	88🔒	Atlanta	US	Series A–Late Stage	$5M – $20M	+ Add to CRM
BI BioAdvance DSFJGHAG18 people · Leads rounds	88🔒	Conshohocken	US	Pre-Seed–Late Stage	$500K – $1.5M	+ Add to CRM
GO GoAhead Ventures CSPBTM3 people · Leads rounds	88🔒	Menlo Park	US	Pre-Seed–Series A	$500K – $1M	+ Add to CRM
CL Claret Capital Partners DBJKBGDM29 people	88🔒	London	GB	Series A–Late Stage	—	+ Add to CRM
NO Novartis Venture Fund AKBDFMLB25 people · Leads rounds	88🔒	Basel	CH	Pre-Seed–Late Stage	$5M – $25M	+ Add to CRM
EC EcoR1 Capital ONCSSMBZ17 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
EM Emles Venture Partners APFYJHJN14 people · Follows rounds	88🔒	New York	US	Pre-Seed–Seed	—	+ Add to CRM
MO Movac PMDBFFJG26 people · Leads rounds	88🔒	Auckland	NZ	Seed–Late Stage	$600K – $3M	+ Add to CRM
SO Solidus Investment	88🔒	Seoul	KR	Seed–Series A	—	+ Add to CRM
VE Verge HealthTech Fund CNEDEMJM24 people	88🔒	Singapore	SG	Pre-Seed–Series B	$500K – $1.5M	+ Add to CRM
KA Karma Ventures KLMUTUAS14 people · Follows rounds	88🔒	Tallinn	EE	Seed–Series B	$1M – $5.4M	+ Add to CRM
ME META Group AMADLAAM38 people	88🔒	Brussels	BE	Seed–Series A	—	+ Add to CRM
NY NYU Innovation Venture Fund FRAIAAAH32 people	88🔒	New York	US	Pre-Seed–Series A	$100K – $500K	+ Add to CRM
BI BioMedPartners ANSFDCDD28 people · Leads rounds	88🔒	Basel	CH	Seed–Late Stage	$648K – $6.5M	+ Add to CRM

New World Angels

Boca RatonSeed–Series A

RTADAJAY37 people

DOMiNO Ventures

AmsterdamSeed–Series B$220K – $1.1M

MKYKBYAK30 people

Karista

ParisPre-Seed–Late Stage$324K – $5.4M

ABBHCBED14 people

NaviMed Capital

RosslynGrowth$5M – $30M

BSBCRSRR29 people

Safar Partners

CambridgePre-Seed–Late Stage

GSBMRMAC20 people

Trendlines Group

MisgavPre-Seed–Late Stage$650K – $15M

HBTDBSNK21 people

UTEC

TokyoPre-Seed–Growth$3.1M – $78M

KM1 person

aMoon

Ra'ananaSeed–Late Stage

IDMMRSRW25 people

ClavystBio

SingaporeSeed–Series A

FAKSKLAT33 people

CitareTx Investment Partners

HoustonSeed–Series A$500K – $2M

JSE"2 people

Noro-Moseley Partners

AtlantaSeries A–Late Stage$5M – $20M

AMATSMVK10 people

BioAdvance

ConshohockenPre-Seed–Late Stage$500K – $1.5M

DSFJGHAG18 people

GoAhead Ventures

Menlo ParkPre-Seed–Series A$500K – $1M

CSPBTM3 people

Claret Capital Partners

LondonSeries A–Late Stage

DBJKBGDM29 people

Novartis Venture Fund

BaselPre-Seed–Late Stage$5M – $25M

AKBDFMLB25 people

EcoR1 Capital

San FranciscoSeed–Late Stage

ONCSSMBZ17 people

Emles Venture Partners

New YorkPre-Seed–Seed

APFYJHJN14 people

Movac

AucklandSeed–Late Stage$600K – $3M

PMDBFFJG26 people

Solidus Investment

SeoulSeed–Series A

Verge HealthTech Fund

SingaporePre-Seed–Series B$500K – $1.5M

CNEDEMJM24 people

Karma Ventures

TallinnSeed–Series B$1M – $5.4M

KLMUTUAS14 people

META Group

BrusselsSeed–Series A

AMADLAAM38 people

NYU Innovation Venture Fund

New YorkPre-Seed–Series A$100K – $500K

FRAIAAAH32 people

BioMedPartners

BaselSeed–Late Stage$648K – $6.5M

ANSFDCDD28 people

Data sourced from public filings and firms' own websites — see our methodology.